Back to Agenda
TOPIC 2: REGULATORY ASPECTS IN PHARMACOVIGILANCE AND PRACTICAL EXAMPLES. SESSION 1: SUSAR Reporting in Clinical Trials and Case Studies
Session Chair(s)
Gaby L. Danan, MD, PhD
Pharmacovigilance Expert
GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
SUSAR Reporting in Clinical Trials and Case Studies
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert
Have an account?